SCHEMBL13089482

SCHEMBL13089482

CC[Si](CC[Si](OC(C)=O)(OC(C)=O)c1ccccc1)(OC(C)=O)OC(C)=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
MTNR1A P48039 7/20 0.34
MTNR1B P49286 7/20 0.34
MAPT P10636 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
CES2 O00748 1/20 0.32
CES1 P23141 1/20 0.32
HDAC6 Q9UBN7 1/20 0.31
HPGD P15428 2/20 0.30
NPSR1 Q6W5P4 1/20 0.30
ELANE P08246 1/20 0.30
LMNA P02545 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ESR1 P03372 1/20 0.30
ITGB3 P05106 1/20 0.30
ITGA2B P08514 1/20 0.30
HMGB1 P09429 1/20 0.30
TSHR P16473 1/20 0.30
GGT1 P19440 1/20 0.30
PTGS1 P23219 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL712780 0.88 ALDH1A1 (0.42) ALDH1A1MTNR1AMTNR1BMAPTL3MBTL1
SCHEMBL13089446 0.86 ALDH1A1 (0.36) ALDH1A1MTNR1AMTNR1BMAPTL3MBTL1
SCHEMBL705416 0.83 ALDH1A1 (0.39) ALDH1A1MTNR1AMTNR1BMAPTL3MBTL1
SCHEMBL704102 0.83 ALDH1A1 (0.41) ALDH1A1MTNR1AMTNR1BMAPTL3MBTL1
SCHEMBL701685 0.82 L3MBTL1 (0.41) ALDH1A1MTNR1AMTNR1BMAPTL3MBTL1
SCHEMBL706255 0.82 L3MBTL1 (0.41) ALDH1A1MTNR1AMTNR1BMAPTL3MBTL1
SCHEMBL706197 0.81 PTGS2 (0.39) ALDH1A1L3MBTL1CES2CES1LMNA
SCHEMBL13300462 0.80 MAPT (0.34) ALDH1A1MTNR1AMTNR1BMAPTL3MBTL1
SCHEMBL6702142 0.79 ALDH1A1 (0.38) ALDH1A1MTNR1AMTNR1BMAPTL3MBTL1
SCHEMBL11339624 0.78 NAAA (0.43) ALDH1A1CES2CES1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100261925-A1 METHOD FOR PRODUCING SILICON COMPOUND JSR CORPORATION (JP) 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261925-A1 METHOD FOR PRODUCING SILICON COMPOUND GMNN, GEMIN5, SEPTIN7 ALDH1A1 3835/4885MTNR1A 4868/4885MTNR1B 4820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.